Plasma GH responses to human GHRH-antagonist in normal subjects

European Journal of Endocrinology

Volumn 134, Issue 1, 1996, Pages 67-72

  Hanew, Kunihiko ^a   Tanaka, Aki ^a   Utsumi, Atsushi ^a   Sugawara, Akira ^a   Abe, Keishi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR ANTAGONIST; GROWTH HORMONE RELEASING FACTOR[1-29]AMIDE[1 N ACETYLTYROSINE 2 DEXTRO ARGININE]; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE;

EID: 0030043732     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340067     Document Type: Article

References (33)

1. 2 as a GRF antagonist on membranes. Endocrinology 1985;117:1759-64
2. Coy DH, Murphy WA, Sueiras-Diaz J. Coy EJ, Lance VA. Structure-activity studies on the N-terminal region of growth hormone releasing factor. J Med Chem 1985;28:181-5
3. Cheng K, Chan WW-S, Barreto A Jr, Convey ED, Smith RG. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′ .5′ -monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989;124:2791-8
4. Goth Ml, Lyons CE, Canny BJ, Thorner MO, Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992;130:939-44
5. Lumpkin MD, McDonald JK, Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist. Endocrinology 1989;124:1522-31
6. Saggese G, Cesaretti G, Cinquanta L, Giannessi N, Bracaloni C, Di Spigna G, et al. Evaluation of 24-hour growth hormone spontaneous secretion: comparison with a nocturnal and diurnal 12-hour study. Horm Res 1991;35:25-9
7. Lee A, Bray GA. Kletzky O, Nocturnal growth hormone secretion does not affect diurnal variations in arginine and glucose-stimulated insulin secretion. Metabolism 1991;40:181-6
8. Ghigo E, Arvat E, Nicolosi M, Bellone J, Valetto MR, Mazza E. Acute clonidine administration potentiates spontaneous diurnal, but not nocturnal, growth hormone secretion in normal short children. J Clin Endocrinol Metab 1990;71:433-5
9. Costin G, Kaufman FR, Brasel JA, Growth hormone secretory dynamics in subjects with normal stature. J Pediatr 1989;115:537-44
10. Ghigo E, Arvat E, Mazza E, Mondardini A, Cappa M, Muller EE. et al. Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night. Acta Endocrinol 1990;122:37-40
11. Martha PM, Blizzard RM, Rogol AD, Atenolol enhances growth hormone release to exogenous growth hormone-releasing hormone but fails to alter spontaneous nocturnal growth hormone secretion in boys with constitutional delay of growth. Pediatr Res 1988;23:393-7
12. Jaffe CA, Friberg RD, Barkan AL, Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. J Clin Invest 1993;92:695-701
13. Rodbard D, Munson PJ, De Lean A. Improved curve-fitting, parallelism testing, characterization of sensitivity and specificity, validation, and optimization for radioligand assays. Radioimmun Rel Proc Med 1978;1:469-505
14. Hanew K, Utsumi A, Sugawara A, Abe K, Enhanced GH responses to combined administration of GHRP and GHRP in patients with acromegaly. J Clin Endocrinol Metab 1994;78:509-12
15. Hanew K, Utsumi A, Sugawara A, Shimizu Y, Ikeda H, Abe K, The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly. J Endocrinol Invest 1994;17:313-21
16. Thorner MO, Vance ML, Horvath E, Kovacs K. The anterior pituitary. In: Wilson JD, Foster DW, editors. Textbook of endocrinology. Philadelphia: W.B. Saunders 1992:221-310
17. Tannenbaum GS. Neuroendocrine control of growth hormone secretion. Acta Paediatr Scand 1991;Suppl 372:5-16
18. Aguila MC, McCann SM, Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism. Endocrinology 1985;117:762-5
19. Eden S, Erikssonn E, Martin JB, Modigh K. Evidence for a growth hormone-releasing factor mediating alpha-adrenergic influence on growth hormone secretion in the rat. Neuroendocrinology 1981;33:24-7
20. Miki N, Ono M, Shizume K, Evidence that opiatergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor (GRF). Endocrinology 1984;114:1950-8
21. Kabayama Y, Kato Y, Murakami Y, Tanaka H, Imura H, Stimulation by α-adrenergic mechanism on the secretion of growth hormone-releasing factor (GRF) from perifused rat hypothalamus. Endocrinology 1986;119:432-4
22. Devesa J, Arce V, Lois N, Tresguerres JAF, Lima L, α2-Adrenergic antagonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men. J Clin Endocrinol Metab 1990;71:1581-8
23. Muller EE, Neural control of somatotropic function. Physiol Rev 1987;67:962-1053
24. Buzi F, Zanotti P, Tiberti A, Monteleone M, Lombardi A, Ugazio AG. Overnight growth hormone secretion in short children: independence of the sleep pattern. J Clin Endocrinol Metab 1993;77:1495-9
25. Arimura A, Merchenthaler I, Culler MD, Iwasaki K, Distribution and release of GRF. In: Labrie F, Proulx L, editors. Endocrinology. Amsterdam: Excerpta Med Found, 1984:827-30
26. McCarthy GF, Beaudet A, Tannenbaum GS, Colocalization of somatostatin receptors and growth hormone-releasing factor immunoreactivity in neurons of the rat arcuate nucleus. Neuroendocrinology 1992;56:18-24
27. Horvath S, Palkovits M, Görcs T, Arimura A, Electron microscopic immunocytochemical evidence for the existence of bidirectional synaptic connections between growth hormone-releasing hormone- and somatostatin-containing neurons in the hypothalamus of the rat. Brain Res 1989;481:8-15
28. Zeitler P, Tannenbaum GS, Clifton DK, Steiner RA, Ultradian oscillations in somatostatin and growth hormone-releasing hormone mRNAs in the brains of adult male rats. Proc Natl Acad Sci USA 1991;88:8920-4
29. Thomas CR, Groot K, Arimura A, Antiserum to rat growth hormone (GH)-releasing factor suppresses but does not abolish antisomatostatin-induced GH release in the rat. Endocrinology 1985;116:2174-8
30. Miki N, Ono M, Shizume K, Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats. J Endocrinol 1988;117:245-52
31. Barkan AL, Shenker Y, Grekin RJ, Vale WW, Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995. Cancer 1988;61:221-6
32. Plotsky P, Vale W, Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophyseal portal circulation of the rat. Science 1985;230:461-7
33. Frohman LA, Downs TR, Clarke IJ, Thomas GB, Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J Clin Invest 1990;86:17-24